Avvinity Therapeutics Limited is an immunotherapy company focused on oncology. Avvinity’s proprietary Alphamer™ platform is protected by a portfolio of patents and enables the discovery and development of multiple candidate molecules. All projects harness a powerful and clinically validated immune mechanism which redirects naturally existing antibodies to treat life-threatening diseases.

For further information, or to explore collaborative opportunities, please contact Nick Staples using info@avvinity.com

Press Release

Privacy Policy

© Copyright 2020 Avvinity Therapeutics Limited; Company number: 09967702;
Registered address: 1st Floor Thavies Inn House, 3-4 Holborn Circus, London, EC1N 2HA;
VAT number: 246336602